Skip to main content
You're viewing the free public version. Create a free account for full research and member tools. Join free
Research Abstract Animal Study

Investıgatıon of the In vitro and In vivo effect of a mixture of Ficus carica L. and Hippophae rhamnoides L. on experımentally induced burns.

Investıgatıon of the In vitro and In vivo effect of a mixture of Ficus carica L. and Hippophae rhamnoides L. on experımentally induced burns in rats.

0:00 / 0:00
0:00 / 0:00

Sign in to access this feature

Create a free account or sign in to use AI summaries, listen to articles, download PDFs, and save to your library.

181 views
Share:

Abstract

INTRODUCTION: In vitro analyses of Ficus carica L. and Hippophae rhamnoides L. (FCHR) extract were conducted on human dermal fibroblast (HDF) cell lines to evaluate cell viability (WST-8 assay) and wound closure rate (scratch assay) across different concentrations. In vivo studies were performed using experimental animals divided into six groups: Healthy control, Burn control, Silver sulfadiazine, Vehicle cream, 1.5 % FCHR, and 4.5 % FCHR formulations. On days 3, 7, 14, and 21, skin samples were collected for the assessment of Tnf-α, Tgf-β1, Il-6, Vegf-a and Mmp-2 gene expression using qRT-PCR, alongside histopathological evaluations. METHODS: In vitro studies assessed the effects of various FCHR concentrations on HDF cell viability and wound closure. In vivo, animals were assigned to six treatment groups as described above. Skin samples were collected at predetermined time points (days 3, 7, 14, and 21) for qRT-PCR analysis of wound healing, inflammatory markers (Mmp-2, Il-6, Tnf-α), angiogenesis-related genes (Tgf-β1 and Vegf-α) and for histopathological examination of tissue regeneration. RESULTS: In vitro assays showed the highest cell proliferation at 15.625 μg/ml and 125 μg/ml FCHR concentrations, with the 15.625 μg/ml group exhibiting the greatest wound closure rate. In vivo, FCHR-treated groups demonstrated faster wound healing compared to the burn control. Expression of inflammatory genes (Mmp-2, Il-6, Tnf-α) was reduced in treatment groups, while expression of wound healing and angiogenesis-related genes (Tgf-β1, Vegf-α) increased by day 21. Histopathological analyses revealed enhanced tissue regeneration and structural recovery in FCHR-treated groups. CONCLUSION: The FCHR cream formulation effectively promotes wound healing in both in vitro and in vivo models through its anti-inflammatory and pro-angiogenic effects. These findings highlight the potential of FCHR in enhancing tissue regeneration and provide a foundation for further detailed histopathological, biochemical, and molecular investigations of the wound healing process.

Affiliation

Handan Uguz Bayrakceken

External References

PubMed ID:
41793960

Comments

Sign in or create a free account to join the conversation.

Sign in to comment

Be the first to comment.

More Research Abstracts

View All Abstracts

Trusted By Professionals and Teams:

The National Health Federation
Stand For Health Freedom
Global Healing Institute
Global Wellness Forum
MAHA Action
Myers Detox
Natural News
Mercola.com

Unlock Evidence-Based Health Research

Join 500,000+ members accessing 10,000+ natural health topics.

Subscribe to our informative Newsletter & Receive

Cancer Fighting Foods Ebook

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.